Target Group Inc.
Company Information
Industry Medicinal Chemicals & Botanical Products
SIC Code 2833
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Country Ontario, Canada
Business Address 20 HEMPSTEAD DRIVE, HAMILTON, , L8W 2E7
Mailing Address 55 ADMINISTRATION ROAD, UNIT 13, VAUGHAN, , L4K-4G9
Phone 905-541-3833
Fiscal Year End 1231
EIN 463610035
Financial Overview
FY2025
-$6.51M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 31, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 7, 2025 | View on SEC |
| 8-K Current report of material events | August 18, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 12, 2025 | View on SEC |
| 10-Q Quarterly financial report | May 9, 2025 | View on SEC |
Annual Reports
10-K March 31, 2026
- Operates a 44,000-square-foot cannabis cultivation facility in Ontario via Canary Rx.
- Owns proprietary 'Wisp' vaporizer technology and single-use pod system via CannaKorp.
Related Companies
Companies in the same industry (SIC: 2833)
Raphael Pharmaceutical Inc.
RAPH Medicinal Chemicals & Botanical Products
Jushi Holdings Inc.
JUSHF Medicinal Chemicals & Botanical Products
FITLIFE BRANDS, INC.
FTLF Medicinal Chemicals & Botanical Products
Adia Nutrition, Inc.
ADIA Medicinal Chemicals & Botanical Products
IM Cannabis Corp.
IMCC Medicinal Chemicals & Botanical Products
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.